This article has been corrected to state that Roche's test detects 14 high-risk HPV types, rather than 13 as originally reported.

By a GenomeWeb staff reporter



NEW YORK (GenomeWeb News) – Roche today announced it has been awarded an exclusive contract by Karolinska University Hospital to provide its cobas HPV Test as a primary screening tool for human papillomavirus in women in Sweden.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.